Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

26 Nov 2018 11:45

RNS Number : 5027I
Adamas Finance Asia Limited
26 November 2018
 

Adamas Finance Asia Limited

(the "Company" or "ADAM")

 

Issue of Equity

 

 

The Company reported in its 2017 Annual Report and Accounts that its investment manager's incentive fee in respect of 2017 was USD 3,503,200. Under the terms of its agreement with Harmony Capital Investors Limited ('Harmony'), 50 per cent of such fee is payable in ADAM shares.

 

Consequently the Company has issued Harmony 1,400,832 ADAM shares calculated using the average share price prescribed in the agreement as at 31 December 2017.

 

The Company will make an application for these shares to be admitted to trading on AIM and trading is expected to commence on 29 November 2018 ("Admission").

 

Following Admission, the Company's enlarged issued share capital will comprise 82,465,205 ordinary shares. The Company does not hold any shares in treasury. The total voting rights in the Company is therefore 82,465,205 ordinary shares and this figure may be used by Shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Harmony's shareholding in ADAM following Admission will represent 1.70% of the total issued share capital of the Company.

In this transaction, Barry Lau acquires via his indirect interest in Harmony, 1,400,832 ordinary shares of no par value each in ADAM. As a result, Mr. Lau is interested in 4,561,400 ordinary shares, representing 5.53% of the Company's issued share capital.

The attached notification gives further detail made in accordance with the requirements of the EU Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Barry Lau

2

 

Reason for the notification

 

a)

 

Position/status

 

Indirect Interest in Harmony Capital Investors Limited

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Adamas Finance Asia Limited

b)

 

LEI

 

2138005R4IVX4O3IQ543

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of no par value in Adamas Finance Asia Limited

 

VGG008271246

 

b)

 

Nature of the transaction

 

Acquisition of shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

nil

1,400,832

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

 

1,400,832

 

USD nil

 

e)  

Date(s) of the transaction

 

22 November 2018

f)

Place of the transaction

Off market

 

 

 

 

Enquiries:

 

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

WH Ireland Limited - Nominated Adviser

James Joyce

James Sinclair Ford

+44 (0) 207 220 1666

 

VSA Capital Limited - Corporate Broker

Andrew Monk

+44 (0) 20 3005 5000

Andrew Raca

Buchanan - Financial PR

Charles Ryland

Victoria Hayns

Henry Wilson

 

+44 (0) 20 7466 5000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOELLFSLLSLRFIT
Date   Source Headline
5th Dec 20169:00 amRNSDirector/PDMR Shareholding
28th Nov 201610:00 amRNSDirector/PDMR Shareholding
23rd Nov 20169:11 amRNSDirector/PDMR Shareholding
31st Oct 20168:05 amRNSDirector/PDMR Shareholding
24th Oct 20162:48 pmRNSDirector/PDMR Shareholding
17th Oct 201612:30 pmRNSDirector/PDMR Shareholding
12th Oct 20168:35 amRNSDirector/PDMR Shareholding
7th Oct 20168:45 amRNSre: redemption of Global Pharm Convertible Bond
6th Oct 20169:26 amRNSRestructuring of Investment in Fortel
29th Sep 20169:31 amRNSDirector/PDMR Shareholding
26th Sep 20167:00 amRNSReceipt of US$820,000 from GCCF
23rd Sep 20162:40 pmRNSDirector/PDMR Shareholding
16th Sep 201610:13 amRNSDirector/PDMR Shareholding
12th Sep 20168:54 amRNSHalf Yearly Report
1st Sep 20167:00 amRNSChange of Adviser
28th Jul 20164:40 pmRNSSecond Price Monitoring Extn
28th Jul 20164:35 pmRNSPrice Monitoring Extension
21st Jul 201610:26 amRNSResult of AGM
6th Jul 20167:00 amRNSGCCF successfully exits Project Media
28th Jun 20168:37 amRNSRepayment of Loan by Portfolio Company
23rd Jun 20168:22 amRNSFinal Results
6th Apr 201610:36 amRNSRealisation of Investment in BRJ
1st Apr 201611:23 amRNSGlobal Pharm Update
31st Mar 20167:00 amRNSChange of Adviser
1st Mar 20169:37 amRNSDealing by Mark Hibbs
27th Jan 20168:01 amRNSGlobal Pharm Update
15th Jan 20169:34 amRNSDirector/PDMR Shareholding
7th Jan 20163:07 pmRNSUpdate on proposed IPO of HKMH
22nd Dec 201510:56 amRNSBroker Update
4th Dec 20157:00 amRNSAdamas AM & Ping An Trust Joint Venture Fund
30th Nov 20152:30 pmRNSGlobal Pharm Update
17th Nov 201512:04 pmRNSHolding(s) in Company
26th Oct 201510:56 amRNSRevised Redemption Agreement with Global Pharm
21st Oct 20158:49 amRNSRevised Redemption Agreement with Global Pharm
5th Oct 20157:00 amRNSADAM to invest a further $3m in Adamas' GCCF
18th Sep 20157:00 amRNSHalf Yearly Report
28th Aug 20157:00 amRNSAdamas Strengthens its Executive Team
20th Aug 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Jul 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
3rd Jul 20157:00 amRNSA1 Filing by HKMH
19th Jun 20157:00 amRNSFinal Results
15th Jun 201512:35 pmRNSUpdate on Disposal of Interest in Global Pharm
15th May 201512:09 pmRNSUpdate on Disposal of Interest in Global Pharm
29th Apr 20157:00 amRNSBroker Update
9th Apr 20158:37 amRNSAppointment of Broker
8th Apr 201510:53 amRNSResult of General Meeting
7th Apr 20154:40 pmRNSSecond Price Monitoring Extn
7th Apr 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20157:00 amRNSUpdate on Disposal of Interest in Global Pharm
20th Mar 20153:11 pmRNSChange of Investing Policy

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.